![CNBX Pharmaceuticals Inc (QB)](/common/images/company/NO_CNBX.png)
CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the experti... CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells. Show more
FIBRA PROLOGIS SECURES MAJORITY OWNER POSITION OF TERRAFINA; MAKES SIGNIFICANT COMMITMENT TO MEXICAN INDUSTRIAL MARKET PR Newswire SAN FRANCISCO, Aug. 6, 2024 SAN FRANCISCO, Aug. 6, 2024...
Taiwan Semiconductor Manufacturing Company (NYSE:TSM) – TSMC exceeded earnings and revenue expectations in the second quarter with $20.82 billion in revenue and a net profit of $7.6...
Prologis Reports Second Quarter Results PR Newswire SAN FRANCISCO, July 17, 2024 Demand improves amid uncertain macroeconomic environment SAN FRANCISCO, July 17, 2024 /PRNewswire/ -- Prologis...
U.S. index futures are registering a significant drop in pre-market trading this Wednesday, with the technology sector being the most affected. At 5:50 AM, Dow Jones futures (DOWI:DJI) fell 78...
Prologis to Announce Second Quarter 2024 Results July 17 PR Newswire SAN FRANCISCO, June 27, 2024 SAN FRANCISCO, June 27, 2024 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD), the global leader in...
Prologis to Participate in Industry Conferences in New York City PR Newswire SAN FRANCISCO, May 28, 2024 SAN FRANCISCO, May 28, 2024 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD), the global leader...
PERFORMANCE TEAM - A MAERSK COMPANY & PROLOGIS LAUNCH NEW EV TRUCK CHARGING DEPOT, POWERED BY NATION'S LARGEST EV TRUCK MICROGRID PR Newswire LOS ANGELES, May 23, 2024 The 9 MW depot can...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00029 | 4.49612403101 | 0.00645 | 0.0075 | 0.0051 | 94835 | 0.00616984 | CS |
4 | -0.00076 | -10.1333333333 | 0.0075 | 0.0079 | 0.0051 | 85709 | 0.00682344 | CS |
12 | -0.00276 | -29.0526315789 | 0.0095 | 0.013 | 0.005 | 155607 | 0.0084106 | CS |
26 | -0.00396 | -37.0093457944 | 0.0107 | 0.018 | 0.005 | 199072 | 0.01090774 | CS |
52 | -0.00726 | -51.8571428571 | 0.014 | 0.0487 | 0.005 | 336343 | 0.01900188 | CS |
156 | -0.17826 | -96.3567567568 | 0.185 | 5.5 | 0.005 | 258483 | 0.04205487 | CS |
260 | -0.29696 | -97.7807046427 | 0.3037 | 5.5 | 0.005 | 268211 | 0.15097396 | CS |
Symbol | Price | Vol. |
---|---|---|
ASIIAccredited Solutions Inc (PK) | $ 0.0009 (50.00%) | 291.27M |
PPJEPPJ Healthcare Enterprises Inc (PK) | $ 0.0002 (19,900.00%) | 259.46M |
AAPJAAP Inc (PK) | $ 0.0001 (0.00%) | 147.95M |
HCMCHealthier Choices Management Corporation (PK) | $ 0.00005 (-50.00%) | 105.53M |
SIRCSolar Integrated Roofing Corporation (PK) | $ 0.0001 (-33.33%) | 96.14M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.